1 |
Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM. Nacetyl- beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease. Arch Intern Med 1983;143:1183-5.
DOI
ScienceOn
|
2 |
Berggard I, Bearn AG. Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem 1968; 243:4095-103.
|
3 |
Cunningham BA, Wang JL, Berggard I, Peterson PA. The complete amino acid sequence of beta 2-microglobulin. Biochemistry 1973;12: 4811-22.
DOI
ScienceOn
|
4 |
Bernier GM, Conrad ME. Catabolsm of human beta-2-microglobulin by the rat kidney. Am J Physiol 1969;217:1359-62.
|
5 |
Peterson PA, Evrin PE, Berggard I. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2- macroglobulin, albumin, and total protein. J Clin Invest 1969;48:1189-98.
DOI
|
6 |
Garcon G, Leleu B, Zerimech F, Marez T, Haguenoer JM, Furon D, et al. Biologic markers of oxidative stress and nephrotoxicity as studied in biomonitoring of adverse effects of occupational exposure to lead and cadmium. J Occup Environ Med 2004;46:1180-6.
DOI
ScienceOn
|
7 |
Chiaramonte C, Cigna RM, Cataliotti F. Microproteinuria as a marker of renal damage in children. Minerva Urol Nefrol 2002;54:237-42.
|
8 |
Terai C. Renal function tests in patients with rheumatoid arthritis. Nihon Rinsho 2005;63 Suppl 1:375-8.
|
9 |
Vogt BA, Avner ED. Renal failure. In: Kliegman RM, Berman RE, Jenson HB, Stanton BM, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders, 2007:2206-13.
|
10 |
Choi Y. Proteinuria and nephrotic syndrome. In: Han JS, editor. Nephrology. 3rd ed. Seoul: Seoul National University Press, 2003:183-9.
|
11 |
Kim HJ, Kang SK. Tubulointerstitial disease. In: Kim HJ, editor. Clinical nephrology. 2nd ed. Seoul: Gwangmoon Publishing Co., 2005:435-42.
|
12 |
Braden GL, O'Shea MH, Mulhern JG. Tubulointerstitial diseases. Am J Kidney Dis 2005;46:560-72.
DOI
ScienceOn
|
13 |
Rosner MH, Bolton WK. Renal function testing. Am J Kidney Dis 2006;47:174-83.
DOI
ScienceOn
|
14 |
Costigan MG, Rustom R, Bone JM, Shenkin A. Origin and significance of urinary N-acetyl-beta, D-glucosaminidase (NAG) in renal patients with proteinuria. Clin Chim Acta 1996;255:133-44.
DOI
ScienceOn
|
15 |
Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830-8.
DOI
ScienceOn
|
16 |
Newman DJ. Cystatin C. Ann Clin Biochem 2002;39(Pt 2):89-104.
DOI
|
17 |
Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-90.
|
18 |
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-63.
|
19 |
Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem 1999;45:1866-8.
|
20 |
Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36:29-34.
DOI
ScienceOn
|
21 |
Piscator M. Early detection of tubular dysfunction. Kidney Int Suppl 1991;34:S15-7.
|
22 |
Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, et al. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-6.
DOI
ScienceOn
|
23 |
Price RG. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992;38 Suppl 1:S14-9.
|
24 |
Agardh CD, Agardh E, Isaksson A, Hultberg B. Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus. Clin Chem 1991;37(10 Pt 1):1696-9.
|